When and Why to Increase Your Mounjaro Dosage

What the SURMOUNT trials established about the dose ladder

The SURMOUNT-1 trial, published in the New England Journal of Medicine, enrolled more than 2,500 adults with obesity over 72 weeks. One finding that gets less attention than the headline weight-loss figures is the structure of the treatment itself: participants were titrated upward through the dose ladder at roughly four-week intervals, and the greatest reductions in body weight were seen at the higher strengths, 10 mg and 15 mg. Average weight loss at 15 mg reached around 20–21% of starting body weight. That gradient exists for a reason. Lower doses do produce meaningful effects for some people, but the licensed programme is designed to move you toward the dose at which you personally get the best response, as determined by your prescriber.

The NHS tirzepatide medicines page describes the schedule factually: treatment starts at 2.5 mg for the first four weeks. The job of that first pen is adjustment, slowing gastric emptying and activating GIP and GLP-1 receptors is a new demand on your system, and beginning low reduces the likelihood of nausea overwhelming everything else. From there, the prescriber steps the dose upward when your body is ready. Each pen covers four weekly injections, so a dose change typically happens when you move to a new pen.

Worth noting: the schedule in clinical trials was protocol-driven and fixed. In practice, your prescriber has more flexibility, they may hold you at a given dose for longer if side effects are still settling, or if progress is already strong at a lower strength. The titration schedule is a framework, not a countdown.

Why increasing the Mounjaro dosage tends to improve results

The reason clinicians increase the dose (rather than keeping everyone at 2.5 mg indefinitely) is pharmacological. Tirzepatide's effect on appetite, satiety and gastric emptying is dose-dependent: higher concentrations at the receptor produce a stronger signal. For most people, the starter strength does not produce the appetite suppression seen at maintenance doses. That is why increasing the Mounjaro dose is a standard part of treatment rather than an escalation reserved for people who are not responding.

There is also a metabolic argument. NICE, in its appraisal of tirzepatide (TA1026), recommends considering stopping treatment if less than 5% weight loss is achieved after six months at the highest tolerated dose. The logic runs in reverse too: reaching and tolerating higher doses is how most people arrive at the weight-loss outcomes the trial evidence describes. That is the primary clinical reason your prescriber monitors progress and considers stepping you up.

For a fuller look at the clinical rationale behind each step, our page on increasing tirzepatide dose covers the pharmacology in more detail. And if you are wondering about the timing (not just the reasoning) when to increase your Mounjaro dose sets out the practical signals your prescriber looks for.

Side effects at higher doses: what to expect

Most of the side effect conversation around Mounjaro focuses on the early weeks, but it is equally relevant at each dose increase. The same GI effects (nausea, loose stools, indigestion, fatigue) can return in a milder form when you step up to a new strength. They usually settle within one to two weeks as your system adjusts again. The relationship between Mounjaro side effects and dosage is nuanced: a small number of people find higher doses persistently uncomfortable and stay at a lower strength by agreement with their prescriber. That is a legitimate outcome; there is no clinical obligation to reach 15 mg.

One practical note: your pen lives in the fridge, ideally somewhere visible, a lot of people keep it in the fridge door. Keeping the routine consistent matters more at higher doses, when the medicine is doing more work. Missing a dose and then restarting at the same strength, or timing a dose change incorrectly, can introduce unnecessary GI disruption. Always follow your prescriber's specific instructions and the Patient Information Leaflet for your current strength.

If you are curious about what separates 5 mg from the doses above it, the Mounjaro 5 mg guide covers that transition specifically. For the full picture of how all six strengths fit together, the Mounjaro dosage overview is a good starting point, and our broader Mounjaro information page covers the medicine as a whole. If you have questions about what the right therapeutic dose looks like for you individually, what the therapeutic dose of tirzepatide means in practice explains the concept clearly.

Dose increases are a clinical decision. If you are on treatment with us and want to discuss your next step, our prescribers are available seven days a week through aftercare support. If you are not yet on a programme and want to understand your options, speak to our prescribers through a free consultation, same-day clinical review, no waiting list.